[go: up one dir, main page]

NO976112L - 1,6-disubstituted isochromes for the treatment of migraine - Google Patents

1,6-disubstituted isochromes for the treatment of migraine

Info

Publication number
NO976112L
NO976112L NO976112A NO976112A NO976112L NO 976112 L NO976112 L NO 976112L NO 976112 A NO976112 A NO 976112A NO 976112 A NO976112 A NO 976112A NO 976112 L NO976112 L NO 976112L
Authority
NO
Norway
Prior art keywords
treatment
isochromes
disubstituted
migraine
useful
Prior art date
Application number
NO976112A
Other languages
Norwegian (no)
Other versions
NO976112D0 (en
Inventor
Michael D Ennis
Ruth E Tenbrink
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO976112D0 publication Critical patent/NO976112D0/en
Publication of NO976112L publication Critical patent/NO976112L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår 1,6-disubstituerte isokromaner av formel (I) og aromatiske, bisykliske aminer (ABA) som er anvendbare for behandling av hodepine, spesielt migrene og klase- hodepine, og også anvendbare som anti- psykotiske midler og for behandling av andre CNS og/eller kardiovaskulære syk- dommer, og som analgetiske midler.The present invention relates to 1,6-disubstituted isochromes of formula (I) and aromatic bicyclic amines (ABA) which are useful for the treatment of headaches, in particular migraine and cluster headaches, and also useful as antipsychotics and for the treatment of other CNS and / or cardiovascular diseases, and as analgesic agents.

NO976112A 1995-06-30 1997-12-29 1,6-disubstituted isochromes for the treatment of migraine NO976112L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US1123496P 1996-02-06 1996-02-06
PCT/US1996/008681 WO1997002259A1 (en) 1995-06-30 1996-06-07 1,6-disubstituted isochromans for treatment of migraine headaches

Publications (2)

Publication Number Publication Date
NO976112D0 NO976112D0 (en) 1997-12-29
NO976112L true NO976112L (en) 1998-03-02

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO976112A NO976112L (en) 1995-06-30 1997-12-29 1,6-disubstituted isochromes for the treatment of migraine

Country Status (12)

Country Link
EP (1) EP0836599A1 (en)
JP (1) JPH11509532A (en)
AU (1) AU6252296A (en)
BR (1) BR9609631A (en)
CA (1) CA2225282A1 (en)
CZ (1) CZ418597A3 (en)
FI (1) FI974640L (en)
MX (1) MX9710260A (en)
NO (1) NO976112L (en)
PL (1) PL324319A1 (en)
SK (1) SK164297A3 (en)
WO (1) WO1997002259A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
BRPI0510642A (en) 2004-05-05 2007-11-20 Hoffmann La Roche arylsulfonyl benzodioxanes useful for modulating 5-ht6 receptor, 5ht2a receptor or both
CN101119989B (en) 2004-12-21 2010-06-09 弗·哈夫曼-拉罗切有限公司 Seman derivatives and their use in the treatment of CNS diseases
AU2005318596B2 (en) 2004-12-21 2010-12-23 F. Hoffmann-La Roche Ag Chroman derivatives and their use as 5-HT receptor ligands
ES2314749T3 (en) 2004-12-21 2009-03-16 F. Hoffmann-La Roche Ag DERIVATIVES OF TETRALINA AND INDANO AND USES OF THE SAME AS 5-HT ANTAGONISTS.
KR100899061B1 (en) 2004-12-21 2009-05-25 에프. 호프만-라 로슈 아게 Tetralin and indane derivatives and uses thereof
PL1831159T3 (en) 2004-12-21 2010-06-30 Hoffmann La Roche Tetralin and indane derivatives and uses thereof
RU2008115032A (en) 2005-11-03 2009-12-10 Ф. Хоффманн-Ля Рош Аг (Ch) ARILSULFONILCHROMANES AS 5-NT6 INHIBITORS
EP2041079A1 (en) 2006-06-20 2009-04-01 F. Hoffmann-Roche AG Arylsulfonyl naphthalene derivatives and uses thereof
CA2655524A1 (en) 2006-06-20 2007-12-27 F. Hoffman-La Roche Ag Arylsulfonamidyl tetralin derivatives and uses thereof
AU2007263084A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN102341367B (en) * 2009-03-05 2014-05-07 住友化学株式会社 Method for producing halogen-substituted benzene dimethanol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
NZ277373A (en) * 1993-12-28 1998-07-28 Upjohn Co Iso(thio)chroman-1-ylethylpiperazine and -piperidine derivatives (analogues)

Also Published As

Publication number Publication date
MX9710260A (en) 1998-03-29
NO976112D0 (en) 1997-12-29
FI974640A7 (en) 1997-12-30
CZ418597A3 (en) 1998-06-17
WO1997002259A1 (en) 1997-01-23
FI974640A0 (en) 1997-12-30
FI974640L (en) 1997-12-30
BR9609631A (en) 1999-03-02
AU6252296A (en) 1997-02-05
SK164297A3 (en) 1998-09-09
CA2225282A1 (en) 1997-01-23
EP0836599A1 (en) 1998-04-22
PL324319A1 (en) 1998-05-25
JPH11509532A (en) 1999-08-24

Similar Documents

Publication Publication Date Title
NO976112L (en) 1,6-disubstituted isochromes for the treatment of migraine
FI935701A0 (en) Fluoroalkoxybenzylamino derivatives of quaternary heterocyclic compounds
FI941022A0 (en) Spirocyclic piperidine derivatives
FI931370A0 (en) QUANTITATIVE ANALOGER AV ICKE-AROMATIC HETEROCYCLISM FOERENINGAR MED EN FUSIONERAD RING
NO955047L (en) Secondary amines such as antidiabetic and anti-obesity agents
MX9702865A (en) 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-idoles as estrogenic agents.
MD1838G2 (en) 5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections
ATE263157T1 (en) NEMATICIDE TRIFLUORBUTENE
NO20003233D0 (en) 4-hydroquinquinoline-3-carboxamides and hydrazines as antivirals
NO991732L (en) New heterocyclylmethyl substituted pyrazole derivatives
NO970161D0 (en) Triazole Compounds and Their Use
NO20006645L (en) New form of irbesartan, process for obtaining said form and pharmaceutical preparations containing the same
DK0737189T3 (en) Heterocyclic Compounds for the Treatment of CNS Disorders and Cardiovascular Disorders
NO971625L (en) Novel peptides with immunomodulatory effects
ATE242220T1 (en) BENZIMIDAZOLE DERIVATIVES WITH DOPAMINERGIC EFFECTS
NO995431D0 (en) Substituted 3,3-diamino-2-propenitriles, their preparation and use
BR0113461A (en) Pharmaceutically acceptable compounds or salts, pharmaceutical compositions, method of treating erab, hadh2 or (beta) -amyloid-mediated disease or condition in mammals, methods of inhibiting or modulating erab or hadh2 enzymatic activity, and method of treating alzheimer's disease or dementia in mammals
NO970573D0 (en) Yliden compounds and their preparation
YU22802A (en) Isonipectoamides for the treatment of integrinmediates disorders
DK0703232T3 (en) 2,3-Dihydro-1H-isoindole derivatives, methods for their preparation and their use as inhibitors of serotonin uptake
ATE265418T1 (en) NEW SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES
HUP0001118A2 (en) N-substituted pyrrolidine derivatives, process for preparing the same and pharmaceutical compositions containing them
DE59406501D1 (en) SUBSTITUTED IMINOACETONITRILE WITH MYOCARD PROTECTIVE EFFECT
NO970498L (en) Benzimidazole derivatives with dopaminergic activity